Controversies surrounding the use of Parathyroid hormone as a marker of bone metabolism in chronic kidney disease(CKD) patients on haemodialysis in Zimbabwe: The way forward.
Full text not available from this repository.Item Type: | Thesis |
---|---|
Depositing User: | Unnamed user with email it@rcz.ac.zw |
Date Deposited: | 10 Jan 2016 01:01 |
Last Modified: | 10 Jan 2016 01:01 |
URI: | http://researchdatabase.ac.zw/id/eprint/3014 |